Searching for your content...
from 8 AM - 10 PM ET
Fustibal LLC (Fustibal), a targeted therapeutics biotechnology startup, today announced that it has filed an inter partes review (IPR) petition of...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.